Summary
Karo Bio AB (Karo Bio) focuses on the development and innovation of drugs. The key research area of the company involves nuclear receptors. The company is involved in preclinical development in the fields of neuropsychiatry, inflammation, autoimmune diseases and cancer. Its projects are based on ROR gamma receptor and estrogen receptor (ER). The studies based on ER beta explore its potential in the treatment of cancer and multiple sclerosis (MS) whereas, the study on ROR receptor is being conducted in collaboration with Pfizer, the study investigates the role of ROR gamma in the development of autoimmune diseases such as rheumatoid arthritis and psoriasis. Karo Bio is headquartered in Huddinge, Sweden.
Karo Bio AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Karo Bio AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Karo Bio AB, Medical Devices Deals, 2010 to YTD 2016 10
Karo Bio AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Karo Bio AB, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Karo Bio Enters Into Research Agreement With 4D Science 12
Karo Bio Extends Research Agreement With Pfizer For RORgamma Modulators 13
Karo Bio Enters Into Research Agreement With Pfizer For RORgamma Modulators 14
Karo Bio Extends Research Agreement With Zydus Cadila 16
Karo Bio Terminates Its Collaboration With Merck & Co For MK-6913 17
Licensing Agreements 18
Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 18
Karo Bio Enters Into Licensing Agreement With Alkem 19
Equity Offering 20
Karo Bio to Raise USD29.7 Million in Rights Offering of Preferred Shares 20
Karo Bio Raises USD29 Million in Rights Offering of Shares 22
Karo Bio Raises USD12 Million in Rights Offering of Shares 24
Karo Bio Raises USD1 Million in Private Placement of Shares 25
Karo Bio Completes Rights Offering of Shares for USD4.9 Million 26
Karo Bio Completes Rights Offering Of US$49 Million 27
Acquisition 29
Karo Bio Acquires Tanomed for USD2.3 Million 29
Karo Bio AB - Key Competitors 30
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33
List of Tables
Karo Bio AB, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Karo Bio AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Karo Bio AB, Deals By Therapy Area, 2010 to YTD 2016 8
Karo Bio AB, Medical Devices Deals, 2010 to YTD 2016 10
Karo Bio AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Karo Bio Enters Into Research Agreement With 4D Science 12
Karo Bio Extends Research Agreement With Pfizer For RORgamma Modulators 13
Karo Bio Enters Into Research Agreement With Pfizer For RORgamma Modulators 14
Karo Bio Extends Research Agreement With Zydus Cadila 16
Karo Bio Terminates Its Collaboration With Merck & Co For MK-6913 17
Karo Bio Enters into Licensing Agreement with Pelago Bioscience for CETSA 18
Karo Bio Enters Into Licensing Agreement With Alkem 19
Karo Bio to Raise USD29.7 Million in Rights Offering of Preferred Shares 20
Karo Bio Raises USD29 Million in Rights Offering of Shares 22
Karo Bio Raises USD12 Million in Rights Offering of Shares 24
Karo Bio Raises USD1 Million in Private Placement of Shares 25
Karo Bio Completes Rights Offering of Shares for USD4.9 Million 26
Karo Bio Completes Rights Offering Of US$49 Million 27
Karo Bio Acquires Tanomed for USD2.3 Million 29
Karo Bio AB, Key Competitors 30
Karo Bio AB, Key Employees 31
Karo Bio AB, Subsidiaries 32
List of Figures
Karo Bio AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Karo Bio AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Karo Bio AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Karo Bio AB, Medical Devices Deals, 2010 to YTD 2016 10